CA2317116A1 - Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs - Google Patents

Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs Download PDF

Info

Publication number
CA2317116A1
CA2317116A1 CA002317116A CA2317116A CA2317116A1 CA 2317116 A1 CA2317116 A1 CA 2317116A1 CA 002317116 A CA002317116 A CA 002317116A CA 2317116 A CA2317116 A CA 2317116A CA 2317116 A1 CA2317116 A1 CA 2317116A1
Authority
CA
Canada
Prior art keywords
construct
culturing
seeding
tissue
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002317116A
Other languages
French (fr)
Inventor
Alvin Peterson
Lee K. Landeen
John Bennett
Jason Gee
Scott Chesla
Joan Zeltinger
James H. Flatt
Mark A. Applegate
Noushin Dunkelman
Stephen V. Kemmerrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Tissue Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2317116A1 publication Critical patent/CA2317116A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)

Abstract

An apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing three-dimensional tissue constructs is disclosed. The apparatus includes a fluid reservoir (18), a pump (30), at least one treatment chamber (10), and a means for controlling media flow characteristics around a tissue construct (20) disposed within the treatment chamber (10), and for controlling movement of the construct itself, so as to simulate a variety of physiologic conditions. One exemplary embodiment of the invention includes a means for applying an axial stress to the construct. Applying an axial stress to the construct during seeding and culturing results in a tissue-engineered construct with cells and their fibers oriented in a manner which is more likely to possess long term dimensional stability and the patency of native vessels with normal physiologic function.

Description

APPARATUS AND METHOD FOR SIMULATING IN VIVO CONDITIONS
WHILE SEEDING AND CULTURING THREE-DIMENSIONAL
TISSUE CONSTRUCTS
Alvin Peterson Lee K. Landeen John Bennett Jason Gee Scott Chesla Joan Zeltinger James Flatt Mark A. Applegate Noushin Dunkelman Stephen Kemmerrer RELATED APPLICATIONS
This application is a continuation-in-part of United States patent application serial number 08/478,309, filed June 7, 1995 and entitled "Apparatus and Method for Sterilizing, Seeding, Culturing, Storing, Shipping, and Testing Tissue, Synthetic, or Mechanical Heart Valves or Valve Segments;" United States patent application serial number 08/912,948, filed August 14, 1997 and entitled "Apparatus and Method for Sterilizing, Seeding, Culturing, Storing, Shipping, and Testing Replacement Cartilage Tissue Constructs," which is a continuation of United States patent application serial number 08/486,185, filed June 7, 1995 and entitled "Apparatus and Method for Sterilizing, Seeding, Culturing, Storing, Shipping, and Testing Replacement Cartilage Tissue Constructs;" and United States patent application serial number 08/672,697, filed June 27, 1996 and entitled "Apparatus and Method for Sterilizing, Seeding, Culturing, Storing, Shipping, and Testing Tissue, Synthetic, or Native Vascular Grafts," which is a continuation-in-part of United States patent application serial number 08/430,768, filed April 27, 1995 and entitled "Apparatus and Method for Sterilizing, Seeding, Culturing, Storing, Shipping, and Testing Tissue, Synthetic, or Native Vascular Grafts."
SUBSTITUTE SHEET (RULE 26) WO 99/33951 PC'T/US9$/27845 Each of the above-referenced applications is hereby incorporated by reference.
SUBSTITUTE SHEET (RULE 26~

WO 99/33951 PGTlUS98/27845 BACKf3R0'DND OF THE INVENTION
Technical Field The present invention relates to the sterilization, seeding, culturing, storing, shipping, and testing of three-s dimensional tissue. Specifically, the present invention relates to an apparatus and method for seeding and culturing three-dimensional tissue constructs with viable mammalian cells under simulated in vivo conditions, resulting in three-dimensional tissue that is more likely to display the biochemical, physical, and structural properties of native tissues.
Discussion of the Related Art Biological implants are presently used by surgeons to repair or replace a variety of native tissues, including heart valves, arterial or venous blood vessels, articular cartilage, tendons, and ligaments, that are weakened, damaged or obstructed due to trauma or disease. Historically, implants have been either homografts, prosthetic grafts made of synthetic materials such as polyester (e. g., Dacron), expanded polytetraflouroethylene (ePTFE), and other composite materials, or fresh or fixed biological tissue grafts.
However, synthetic grafts generally have inadequate patency rates for many uses, while the harvesting of homografts requires extensive surgery which is time-consuming, costly, and traumatic to the patient. Fixed tissue grafts do not allow for infiltration and colonization by the host cells, which is essential to remodeling and tissue maintenance. Consequently, fixed tissue grafts degrade with time and will eventually malfunction.
Due to the inadequacies of these currently available synthetic and biological grafts, as well as the cost and limited supply of homografts, tissue-engineered grafts are being developed which are seeded and cultured, in vitro, with SUBSTITUTE SHEET (RULE 26) cells. For example, U.S. Patent No. 5,266,480 to Naughton et al. discloses the establishment o~ a three-dimensional matrix, seeding of the matrix with desired cells, and maintenance of the culture to provide a variety of three-dimensional tissues suitable for use in different applications. Tissue-engineered grafts utilizing this technology may be superior to other grafts for use in replacement therapy in that they more closely display the long term dimensional stability and patency of native arteries and vessels with normal physiologic functionality.
Historically, the seeding and culturing of such grafts, and tissue in general, has taken place in a static environment such as a Petri or culture dish. However, there are disadvantages to seeding and culturing tissue in such an environment. For example, the lack of circulation of nutrients in these static systems results in a slow and ineffective seeding and culturing process. Moreover, a static culturing environment may lead to de-differentiation and loss of tissue function, and cannot support growth of tissue beyond a certain thickness.
In contrast, tissues that are seeded and cultured in a dynamic environment can be grown to a wider range of thicknesses, and are more likely to tolerate the physiological conditions that exist in the human body once implanted. Thus, there exists a need for an environment that is designed to simulate physiologic conditions that particular tissues would be subjected to in vivo, in which to seed and culture tissue-engineered grafts and other prosthetic devices.
SCARY OF TfIE INVENTION
It is therefore an object of the invention to provide an apparatus for seeding and culturing tissue constructs which is designed to simulate physiologic conditions that a SUBSTITUTE SHEET (RULE 26) particular construct would be subjected to in vivo by controlling the growth media flow through and across the construct, and the movement of the construct itself, to create varying physiologic-like pressures and forces which act upon the growing tissue.
It is a further object of the invention to stimulate the production of replacement tendon and ligament tissue constructs which display the critical biochemical, physical, and structural properties of native human tendon and ligament tissue by seeding and culturing the tissue in a dynamic environment.
It is a further object of the invention to provide a precise mechanical device with a minimum of moving parts to provide such environments.
It is yet a further object of the invention to provide a closed system free from contamination for sterilizing, seeding, culturing, storing, shipping, and testing tissue constructs.
In accordance with the present invention, there is provided an apparatus and method for seeding and culturing tissue constructs with viable mammalian cells under simulated in vivo conditions, resulting in three-dimensional tissue that is more likely to display the biochemical, physical, and structural properties of native tissues.
One exemplary embodiment of an apparatus according to the invention comprises a fluid reservoir, at least one construct treatment chamber, a support structure for supporting the construct in the treatment chamber, and a means for placing an axial load on the construct. By placing an axial load on the construct in the treatment chamber during culturing, an axial stress is placed on the construct.
This stress results in a tissue-engineered tendon or ligament construct with cells and their fibers oriented in a manner which is more likely to possess long term dimensional SUBSTITUTE SHEET (RULE 26~

WO 99/33951 PC'T/US98I27845 stability and the patency of, for example, native tendons or ligaments with normal physiologic function. In this manner, one embodiment of the invention advantageously utilizes a mechanically non-complex apparatus to create a dynamic environment in which to seed and culture tissue-engineered tendons, ligaments or other implantable devices.
SUBSTITUTE SHEET (RULE 26) BRIEF DESCRIPTION OF THE DR~WINC~S
These and other features, aspects, and advantages of the present invention will become more readily apparent from the following detailed description, which should be read in conjunction with the accompanying drawings in which:
FIG. 1 illustrates an apparatus according to the present invention for sterilizing, seeding, culturing, storing, shipping, and testing a prosthesis in which a magnetic axial loading is utilized;
FIG. 2 illustrates an apparatus according to the present invention for sterilizing, seeding, culturing, storing, shipping, and testing a prosthesis in which a mechanical axial loading is utilized, and wherein the mechanical loading is generated using a piston;
FIG. 3 illustrates an apparatus according to the present invention for sterilizing, seeding, culturing, storing, shipping, and testing a prosthesis in which a mechanical axial loading is utilized, and wherein the mechanical loading is generated using a bellows; and FIG. 4 illustrates yet another alternative exemplary embodiment of an apparatus according to the present invention for sterilizing, seeding, culturing, storing, shipping, and testing a prosthesis in which a flexible diaphragm is utilized to provide an axial load.
DETAILED DESCRIPTION OF THE INVENTION
The following embodiments of the present invention will be described in the context of an apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing tendon and ligament constructs, although those skilled in the art will recognize that the disclosed methods and structures are readily adaptable for broader application.
Note that whenever the same reference numeral is repeated SUBSTITUTE SHEET (RULE 2B) with respect to different figures, it refers to the corresponding structure in each such figure.
FIG. 1 discloses a system for sterilizing, seeding, culturing, storing, shipping, and testing tendon and ligament constructs. According to a preferred embodiment of the invention, this system primarily comprises a treatment chamber 10, a pump 30, and a media reservoir 18 fluidly communicating with the treatment chamber.
Media reservoir 18 is used to store fluid for the system. Illustrative suitable reservoirs are the Gibco-BRL 1L
media bag or any rigid container capable of sterilization.
Reservoir 18 may include a one way sterile filter so as to provide a direct source of filtered gas to the fluid within the system or, alternatively, may include gas-permeable tubing or membranes comprised of a material such as silicone or Teflon so as to provide an indirect source of sterile gas to the system via diffusion. Examples of fluid which may be used in the system include, but are not limited to, sterilizing fluid, tanning fluid, cryopreservative fluid, rinse fluid, fluid containing cells, or fluid containing a culture medium. It is to be understood that during testing, seeding, and culturing in a preferred embodiment, the fluid is advantageously kept at human body temperature through use of an incubator, for example, and may be composed of a fluid which approximates the viscosity of human blood or other human bodily fluids.
The fluid contained in reservoir 18 is retrieved through either fluid line 14 or 15 into treatment chamber 10 through the action of pump 30, which, as discussed below, controls the flow of fluid within the system. Fluid lines 14 and 15, as well as all other fluid lines in the system, may be made of any type of stainless steel tubing or medical grade, sterilizable, durable, plastic tubing preferably comprised of _ g -SUBSTITUTE SHEET (RULE 26) a gas-permeable material such as silicone which is suitable for transporting the fluid in use.
Treatment chamber 10 is preferably composed of any biocompatible, rigid material capable of being sterilized such as Teflon, polycarbonate, PVC, stainless steel, acrylic, polypropelene, and polyethylene. Treatment chamber 10 may be a single piece of material or may comprise two or more sections which are secured and made leak proof through any standard means such as inner and outer threads, an o-ring seated in an annular groove, a clamp, or bonding agents. In order to view construct 20 within treatment chamber 10, a viewing port may be placed at any point on the chamber, or alternatively, the chamber may be made of an optically clear material such as polycarbonate or PVC. Ports 16 and 17 of treatment chamber 10 allow for the perfusion and/or circulation of fluid into and through chamber 10. Ports 16 and 17 are also used to attach treatment chamber 10 to fluid lines 14 and 15 respectively.
As mentioned, pump 30 controls the flow of the fluid within treatment chamber 10. Pump 30 may be any pump capable ZO of providing unidirectional or bidirectional pulsatile or continuous pressure fluid flow in the system. Examples of such pumps include but are not limited to low flow pumps, invasive pumps such as a lobe-type pump, or non-invasive pumps such as a peristaltic pump. Thus, illustratively, when pump 30 is operating so as to force fluid from reservoir 18 to fluid line 14, and subsequently from fluid line 14 into chamber 10, fluid is forced from port 16 through chamber 10 to port 17. However, if pump 30 is operated so as to provide fluid flow in the opposite direction, fluid is then forced in an opposite direction from port 17 through chamber 10 to port 16.
It is to be understood that the pressure from pump 30 may be varied during use so as to provide varying pressure SUBSTITUTE SHEET (RULE 26~

within treatment chamber 10. Moreover, it is to be understood that pump 30 may be operated bidirectionally in any manner and at any interval. Thus, pump 30 may be operated so as to provide bidirectional fluid flow in an alternating fashion at some predetermined interval.
Alternatively, pump 30 may provide fluid flow in one direction for a predetermined period of time followed by fluid flow in the opposite direction for a similar period of time, or may provide fluid flow solely in one direction.
Moreover, it is to be understood that, alternatively, one skilled in the art could devise a suitable valving system (e. g., through the use of a rotating valve) that could also provide chamber 10 with a bidirectional fluid flow.
Treatment chamber 10 is configured and dimensioned to house a tendon or ligament construct 20. Construct 20 may illustratively consist of any knitted, braided, woven, felted, or synthesized material that is bioresorbable and/or biocompatible, as well as any native material which will support appropriate cells. Treatment chamber 10 may be made any size so as to hold a construct 20 of any length or diameter. This is advantageous, as the system may be used to sterilize, seed, culture, store, ship, and test constructs of any size.
In a preferred embodiment of the present invention, construct 20 is secured to the top of treatment chamber 10 by any well known means. Such means include, but certainly are not limited to, sewing, lashing, adhesive bonding, clamping, welding, staking, pinching, or heat bonding.
A magnet 12 is attached to the lower end of construct 20 by any similarly well known means, such as those listed above. Magnet 12 may be comprised of any material that has the property of producing a magnetic field external to itself, including iron, steel or an alloy that has had this property artificially imparted. Alternatively, magnet 12 may SUBSTITUTE SHEET (RULE 26) WO 99/33951 PCT/US9$/27845 be any material that has the property of being attracted by an external magnetic field.
As shown in FIG. 1, also included within the system is a magnetic field generator 22 for applying a magnetic field to magnet 12. Magnetic field generator 22 includes a device or material that is capable of producing a magnetic field, such as a magnetized bar of iron or steel, or a solenoid.
Magnetic field generator 22 further includes a means for varying the magnetic field to be applied to magnet 12. If generator 22 includes a solenoid, the current applied to the solenoid may be varied so as to vary the strength of the solenoid's magnetic field. If generator 22 includes a bar magnet, it will also include a means for moving that magnet closer or nearer to magnet 12 so as to vary the magnetic field applied to magnet 12. One skilled in the art will appreciate that any well known method of imparting movement may be used to move the magnet, including a cam or motor driven push rod or screw. To place an axial load on construct 20, one skilled in the art will also appreciate that if magnet 12 is magnetized, field generator 22 need not also be magnetized, and need only comprise a material that is attracted by an external magnetic field.
By varying the magnetic field applied to magnet 12, the axial load on the construct may likewise be varied. It will thus be appreciated that the axial load may be varied to any extent and at any interval, or may be maintained as a constant. This is advantageous as the ideal axial load to be applied to the construct will vary with time due to the increasing density of the construct during seeding and culturing. Moreover, the ideal axial load to be applied necessarily depends from the outset on the original length and thickness of the construct, and may thus vary from treatment to treatment.

SUBSTITUTE SHEET (RULE 26) Perhaps most importantly, axial load variation is advantageous because stress is placed on construct 10 which resembles the physiological conditions typically encountered by tendons or ligaments in the human body. These culturing conditions are advantageous as they may improve the flow of nutrients to and removal of waste products from cells embedded in the construct. These conditions are also advantageous as they can be detected by living cells attached to construct 20, thus causing the cells to align and configure themselves in a manner more likely to tolerate the physiological conditions found in the human body.
FIG. 2 discloses an alternative embodiment of a system for sterilizing, seeding, culturing, storing, shipping, and testing tendon and ligament constructs. This system primarily comprises a treatment chamber 50, a pump 30, a piston 54, and a media reservoir 18 communicating with the treatment chamber.
Pump 30, media reservoir 18, fluid lines 14 and 15, ports 16 and 17, and the fluids which the system may contain are the same as those disclosed in conjunction with FIG. 1.
Chamber 50 is identical to chamber 10, except chamber 50, unlike chamber 10, is sealed at one end by a piston. As with the system disclosed in FIG. 1, the fluid contained in reservoir 18 may be retrieved through fluid lines 14 or 15 into treatment chamber 50 through the action of pump 30, wh~.ch controls the unidirectional or bidirectional flow and pressure of the fluid within the system. Also, as with the system disclosed in FIG. l, construct 20 is secured to one end of treatment chamber 50. As set forth below, what differs from the embodiment disclosed in FIG. 1 is the means by which an axial load is placed on construct 20.
As shown in FIG. 2, the end of chamber 50 at which construct 20 is attached is also attached to a fixed structure 52. The opposite end of construct 20 is attached SUBSTITUTE SHEET (RULE 26) to a piston 54. Piston 54 is configured and dimensioned, using for example an o-ring, to create a hermetically sealed chamber 50. Force is applied to piston 54 in either direction by a force generator 56. Force generator 56 comprises any well known means for providing bidirectional linear force to a piston, such as an electrically-driven rotating cam, an electromechanical or pneumatic displacement device, or an electrically or pneumatically-driven lever arm.
Alternatively, force may be applied to piston 54 by varying the fluid flow, and thus the pressure; within chamber 10. It is to be understood that the force applied to piston 54 may be varied so as to provide a varying axial load on construct within treatment chamber 50 during use. As with the system disclosed in FIG. l, this varying axial load is advantageous because stress is placed on construct 20 which 15 resembles the physiological conditions typically encountered by tendons or ligaments in the human body. This is additionally advantageous as the ideal load to be applied to the construct will vary with time due to the increasing density of the construct during seeding and culturing.
20 Moreover, the ideal load to be applied necessarily depends from the outset on the original length and thickness of the construct, and may thus vary from treatment to treatment.
FIG. 3 discloses yet another alternative embodiment of the invention for sterilizing, seeding, culturing, storing, shipping, and testing tendon or ligament constructs.
According to this alternative exemplary embodiment of the invention, the system primarily comprises a bellows 100, a pump 30, and a media reservoir 18.
Pump 30, media reservoir 18, fluid lines 14 and 15, ports 16 and 17, and the fluids which the system may contain 0 are the same as those disclosed in conjunction with FIGS. 1 and 2. As with the systems disclosed in FIGS. 1 and 2, the fluid contained in reservoir 18 may be retrieved through SUBSTITUTE SHEET (RULE 26) fluid lines 14 or 15 into treatment chamber 10 through the action of pump 30, which controls the unidirectional or bidirectional flow and pressure of the fluid within the system.
Also, as with the system disclosed in FIG. 2, construct 20 is secured to one end of treatment chamber 10, with that end of chamber 10 likewise attached to a fixed structure 52.
What differs from the embodiments disclosed in FIGS. 1 and 2 is the means by which an axial load is placed on construct 20. In particular, the opposite end of construct 20 is attached to bellows 100, rather than a piston or magnet.
Bellows 100 may comprise a hard-sided blow molded collapsible bellows cassette. However, one skilled in the art will understand that other types of bellows which include at least one rigid surface and flexible edges may be used.
Bellows 100 may also include an external pull ring 102 for easy expansion, and may further include a sealable slit along one of the collapsible side walls so as to place construct 20 within the bellows for treatment. However, it is to be understood that a sealable slit may be placed at any location on bellows 100.
Construct 20 is attached to bel-lows 100 by any well known means, such as sutures, staples, or c-clips, or may be sandwiched between two opposable interlocking structures.
Construct 20 may also be attached to bellows 100 by those attachment means mentioned in conjunction with FIG. 1.
As shown in FIG. 3, a force may be applied to bellows 100 by force generator 56 so as to apply an axial load to construct 20. As mentioned in conjunction with FIG. 2, force generator 56 comprises any well known means for providing force in two directions, such as an electrically-driven rotating cam, an electromechanical or pneumatic displacement device, or an electrically or pneumatically-driven lever arm.
Alternatively, force may be applied to bellows 100 by varying SUBST1TUTE SHEET (RULE 26) WO 99/33951 PCT/US98/2'f845 the fluid flow, and thus pressure, within the bellows. It is also to be understood that the force applied to bellows 100 may be varied so as to provide a varying axial load on construct 20 within bellows 100 during use. Like the systems of FIGS. 1 and 2, an axial load is thus accomplished during seeding, culturing, and testing which closely resembles the physiological conditions found in the human body.
FIG: 4 discloses yet another alternative embodiment of the invention for sterilizing, seeding, culturing, storing, shipping, and testing tendon and ligament constructs.
According to this alternative exemplary embodiment of the invention, the system primarily comprises a chamber 150, a pump 30, and a media reservoir 18. Pump 30, media reservoir 18, fluid lines 14 and 15, ports 16 and 17, and the fluids which the system may contain are the same as those disclosed in conjunction with FIGS. 1-3.
As shown in FIG. 4, chamber 150 comprises rigid upper and lower frame members 152 and 153 connected by a flexible diaphragm 154. Construct 20 is attached to opposing sides of flexible diaphragm 154 by any well known means, including those mentioned in conjunction with FIGS. 1 and 3.
In the exemplary embodiment of the invention disclosed in FIG. 4, pump 30 controls both the flow of the fluid within treatment chamber 150 and the pressure within that treatment chamber. Pump 30 may be any pump capable of providing unidirectional or bidirectional pulsatile or continuous pressure fluid flow in the system. Examples of such pumps include but are not limited to low flow pumps, invasive pumps such as a lobe-type pump, or non-invasive pumps such as a peristaltic pump. Thus, illustratively, when pump 30 is operating so as to force fluid from reservoir 18 to fluid line 14, and subsequently from fluid line 14 into chamber 150, fluid is forced from port 16 through chamber 150 to port 17. However, if pump 30 is operated so as to provide fluid SUBSTITUTE SHEET (RULE 26) WO 99/33951 PCT/US98l27845 flow in the opposite direction, fluid is then forced in an opposite direction from port 17 through chamber 150 to port 16.
It is to be understood that the pressure from pump 30 may be varied during use so as to provide varying pressure within treatment chamber 150. By varying the pressure from pump 30, flexible diaphragm 154 may be expanded and contracted. By expanding and contracting flexible diaphragm 154, a varying axial load is placed on construct 20, attached as mentioned to opposing sides of diaphragm 154. This varying axial load is advantageous because an axial stress is placed on construct 20 which resembles the physiological conditions typically encountered by tendons or ligaments in the human body. This is additionally advantageous as the ideal load to be applied to the construct will vary with time due to the increasing density of the construct during seeding and culturing. Moreover, the ideal load to be applied necessarily depends from the outset on the original length and thickness of the construct, and may thus vary from treatment to treatment.
ZO In an alternative embodiment of the system disclosed in FIG. 4, only one port to chamber 150 is provided. As in the two-port embodiment, the one port may be used to circulate fluids into and out of treatment chamber 150, and to pressurize and depressurize chamber 150. One skilled in the art will understand that if only one port is used, pressure can be applied using, for example, a pump, piston or pressurized air.
It is to be understood that any ports of treatment chamber 10 (in FIG. 1), chamber 50 (in FIG. 2), bellows 100 (in FIG. 3), and chamber 150 (in FIG. 4) (hereinafter collectively referred to as the "treatment devices") may be sealed in a known manner (e. g., luer locks, o-ring based connectors, or threaded plugs) so as to create a sealed SUBSTITUTE SHEET (RULE 26) treatment device free from contamination. The sealed treatment devices may be used to sterilize, store, and ship tendon and ligament constructs or other protheses. In particular, prior to placing a sealed treatment device into the systems of FIGS. 1 - 4, a construct 20 which is secured within the treatment device may be sterilized by some chemical means such as ethylene oxide or peracetic acid, radiation means such as an electron beam or gamma rays, or by steam sterilization. Sealed treatment devices, containing the sterilized tendon or ligament support material, may then be placed back into the systems of FIGS. 1 - 4 for seeding and culturing and unsealed without contaminating the system or the tissue construct. Alternatively, the system may be aseptically assembled after sterilization if it is necessary or desirable to use different means to sterilize the treatment devices and the tissue construct.
Seeding and culturing of the constructs in the systems disclosed in FIGS. 1 - 4 is generally accomplished by known techniques, with the added benefits and advantages gained from the stress placed upon the construct during seeding or growth steps. Examples of suitable seeding and culturing methods for the growth of three-dimensional tissue cultures are disclosed in U.S. Application No. 08/463,566, entitled "Three-Dimensional Cartilage Cultures" and filed on June 5, 1995, and U.S. Patent No. 5,266,480, both of which are incorporated herein by reference. The techniques described in this application and U.S. Patent for establishing a three-dimensional construct, inoculating the construct with the desired cells, and maintaining the culture may be readily adapted by a person of ordinary skill in the art for use with the present invention.
puce construct 20 has reached the desired level of cell density, a preservative may then be pumped into the treatment device. Once the device is filled with the preservative, any SUBSTITUTE SHEET (RULE 26) ports located on the device may be closed, again creating a sealed device which may then be used to store and/or ship the cultured and preserved construct. Preferably, the preservative is a cryo-preservative so that the construct may be frozen in the treatment device. In this manner, the sealed treatment devices may be used to sterilize, culture, store, and ship tendon and ligament constructs or other protheses.
Various .embodiments of the invention have been described. The descriptions are intended to be illustrative, not limitative. Thus, it will be apparent to those skilled in the art that modifications may be made to the invention as described without departing from the scope of the claims set out below. For example, it will be recognized that the exemplary embodiments disclosed in conjunction with FIGS. 1-4 need not have both an inlet and an outlet port to apply an axial stress to the construct during culturing, but instead may have a plurality of ports, one port, or no ports.
Likewise, if only a constant axial load on the tissue construct is desired, magnet 12 in FIG. 1 may, for example, be replaced with a non-magnetized dead weight. Similarly, an axial load can be placed on the constructs shown in FIGS. 2, 3, and 4 by varying the pressure external to the treatment chamber through, for example, the creation of a vacuum around the exterior of the chamber. This is advantageous as fluid access to the treatment chamber is not required.

SUBSTITUTE SHEET (RULE 26)

Claims

CA002317116A 1997-12-31 1998-12-30 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs Abandoned CA2317116A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/001,609 US6121042A (en) 1995-04-27 1997-12-31 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
US09/001,609 1997-12-31
PCT/US1998/027845 WO1999033951A1 (en) 1997-12-31 1998-12-30 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs

Publications (1)

Publication Number Publication Date
CA2317116A1 true CA2317116A1 (en) 1999-07-08

Family

ID=21696959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002317116A Abandoned CA2317116A1 (en) 1997-12-31 1998-12-30 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs

Country Status (7)

Country Link
US (1) US6121042A (en)
EP (1) EP1042448A1 (en)
JP (1) JP4104822B2 (en)
KR (1) KR20010024824A (en)
AU (1) AU772414B2 (en)
CA (1) CA2317116A1 (en)
WO (1) WO1999033951A1 (en)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066495A (en) * 1998-03-05 2000-05-23 Tissue Engineering, Inc. Methods and apparatus for the conditioning of ligament replacement tissue
US20080077251A1 (en) * 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US20100030340A1 (en) * 1998-06-30 2010-02-04 Wolfinbarger Jr Lloyd Plasticized Grafts and Methods of Making and Using Same
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6293970B1 (en) 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
JP2002529073A (en) * 1998-11-12 2002-09-10 セル サイエンス セラピューティックス インコーポレーテッド Generation of lymphoid tissue-specific cells from hematopoietic progenitor cells on a three-dimensional device
US20040018226A1 (en) * 1999-02-25 2004-01-29 Wnek Gary E. Electroprocessing of materials useful in drug delivery and cell encapsulation
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US6592623B1 (en) 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US20020081732A1 (en) * 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US20040116032A1 (en) * 1999-02-25 2004-06-17 Bowlin Gary L. Electroprocessed collagen
US6287340B1 (en) 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
US20020095157A1 (en) 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
JP4601746B2 (en) * 1999-10-25 2010-12-22 エイブル株式会社 Three-dimensional animal cell culture apparatus and culture method
US6503273B1 (en) * 1999-11-22 2003-01-07 Cyograft Tissue Engineering, Inc. Tissue engineered blood vessels and methods and apparatus for their manufacture
AU2001243581A1 (en) * 2000-03-11 2001-09-24 The Trustees Of Columbia University In The City Of New York Bioreactor for generating functional cartilaginous tissue
AU2001251599B2 (en) * 2000-04-14 2006-03-02 University Of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
US7585323B2 (en) * 2000-05-05 2009-09-08 Medlden, Llc In vitro mechanical loading of musculoskeletal tissues
EP1167517A1 (en) * 2000-06-22 2002-01-02 IsoTis N.V. Tissue engineering
AU2001288692A1 (en) * 2000-09-01 2002-03-13 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed fibrin-based matrices and tissues
US20020146817A1 (en) * 2000-10-02 2002-10-10 Cannon Thomas F. Automated bioculture and bioculture experiments system
US7270996B2 (en) * 2000-10-02 2007-09-18 Cannon Thomas F Automated bioculture and bioculture experiments system
US7840393B1 (en) 2000-10-04 2010-11-23 Trivascular, Inc. Virtual prototyping and testing for medical device development
US7063942B2 (en) * 2000-10-06 2006-06-20 Victor Krstec System and method to simulate hemodynamics
DE10061704A1 (en) * 2000-12-12 2002-06-20 Hans Joerg Bauer Method and device for producing biological tissue in a growth chamber
GB0031089D0 (en) * 2000-12-20 2001-01-31 Univ London Tissue growth method and apparatus
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US6852330B2 (en) * 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US20020127265A1 (en) * 2000-12-21 2002-09-12 Bowman Steven M. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US7326564B2 (en) 2001-02-20 2008-02-05 St. Jude Medical, Inc. Flow system for medical device evaluation and production
CA2438904C (en) * 2001-02-23 2012-09-04 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US7029838B2 (en) 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
JP2002306157A (en) * 2001-04-17 2002-10-22 Takagi Ind Co Ltd Apparatus for culturing cell and tissue
JP2002315566A (en) * 2001-04-24 2002-10-29 Takagi Ind Co Ltd Cell and tissue-culturing apparatus
DE10130512B4 (en) * 2001-06-25 2007-08-16 Bionethos Holding Gmbh Device for pressure perfusion for growing and / or treating cells
US20030110830A1 (en) * 2001-07-23 2003-06-19 Mark Dehdashtian Methods and apparatuses for measuring the compliance of stents and stented grafts
JP2003061642A (en) * 2001-08-30 2003-03-04 Takagi Ind Co Ltd Cell and tissue-culturing device
JP4398125B2 (en) * 2001-12-05 2010-01-13 高木産業株式会社 Cell / tissue culture equipment
US7504258B2 (en) * 2001-12-11 2009-03-17 Cytograft Tissue Engineering, Inc. Tissue engineered cellular sheets, methods of making and use thereof
US6776604B1 (en) * 2001-12-20 2004-08-17 Trivascular, Inc. Method and apparatus for shape forming endovascular graft material
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US7090693B1 (en) * 2001-12-20 2006-08-15 Boston Scientific Santa Rosa Corp. Endovascular graft joint and method for manufacture
JP2005512687A (en) * 2001-12-20 2005-05-12 トリバスキュラー,インコーポレイティド Method and apparatus for producing an endovascular graft section
US6881569B2 (en) 2002-01-25 2005-04-19 Children's Medical Center Corporation Apparatus and method for evaluating tissue engineered biological material
WO2003072128A2 (en) * 2002-02-22 2003-09-04 Ebi, L.P. Methods and compositions for treating bone or cartilage defects
US20030176516A1 (en) * 2002-03-15 2003-09-18 Greene, Tweed Of Delaware, Inc. Cellular perfluoroelastomeric compositions, sealing members, methods of making the same and cellular materials for medical applications
US7348175B2 (en) * 2002-03-15 2008-03-25 St3 Development Corporation Bioreactor with plurality of chambers for conditioning intravascular tissue engineered medical products
AU2003218572B2 (en) 2002-04-08 2009-08-20 Octane Biotech, Inc. Automated tissue engineering system
AU2003234197A1 (en) * 2002-04-22 2003-11-03 Tufts University Multi-dimensional strain bioreactor
US7229820B2 (en) * 2002-06-13 2007-06-12 Wilson Wolf Manufacturing Corporation Apparatus and method for culturing and preserving tissue constructs
US6810751B2 (en) * 2002-07-29 2004-11-02 Michael R. Moreno Method and apparatus for vascular durability and fatigue testing
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US20050059153A1 (en) * 2003-01-22 2005-03-17 George Frank R. Electromagnetic activation of gene expression and cell growth
WO2004076608A2 (en) * 2003-02-26 2004-09-10 Georgia Tech Research Corporation Bioreactor and methods for tissue growth and conditioning
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
CN1812800B (en) * 2003-04-25 2013-01-16 匹兹堡大学 Muscle derived cells(mdc) for promoting and enhancing nerve repair and regeneration
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) * 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US7410792B2 (en) * 2003-09-19 2008-08-12 St3 Development Corporation Instrumented bioreactor with material property measurement capability and process-based adjustment for conditioning tissue engineered medical products
US20050095711A1 (en) * 2003-11-01 2005-05-05 More Robert B. Bioreactor for growing engineered tissue
WO2005047466A2 (en) 2003-11-04 2005-05-26 Case Western Reserve University Apparatus and method for tissue engineering
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US20050153438A1 (en) * 2004-01-09 2005-07-14 Akio Shirasu Vessel for cell culture
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
EP1743025A4 (en) * 2004-03-29 2007-12-05 Cytomatrix Llc Methods for production of regulatory t cells and uses thereof
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8657881B2 (en) * 2004-04-20 2014-02-25 Depuy Mitek, Llc Meniscal repair scaffold
EP1745121B1 (en) * 2004-05-06 2019-04-03 University Hospital of Basel Bioreactor for tissue engineering
AU2005247967B2 (en) 2004-05-26 2011-09-01 Octane Biotech, Inc. Advanced tissue engineering system
US7767446B2 (en) * 2004-09-16 2010-08-03 Becton, Dickinson And Company Perfusion bioreactors for culturing cells
US20070026517A1 (en) * 2004-10-19 2007-02-01 Ronny Schulz Method and bioreactor for the cultivation and stimulation of three-dimensional, vitally and mechanically reistant cell transplants
US8603806B2 (en) * 2005-11-02 2013-12-10 The Ohio State Universtiy Research Foundation Materials and methods for cell-based assays
WO2007070301A2 (en) * 2005-12-05 2007-06-21 Regeneration Technologies, Inc. Vascular graft sterilization and decellularization
WO2008021127A2 (en) * 2006-08-08 2008-02-21 Howmedica Osteonics Corp. Expandable cartilage implant
WO2008061261A2 (en) * 2006-11-17 2008-05-22 Cytograft Tissue Engineering, Inc. Preparation and use of cell-synthesized threads
US9125743B2 (en) * 2007-07-16 2015-09-08 Lifenet Health Devitalization and recellularization of cartilage
US20090024224A1 (en) * 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
US9410113B2 (en) * 2007-10-26 2016-08-09 St3 Development Corporation Bioreactor system for three-dimensional tissue stimulator
JP5666131B2 (en) * 2008-02-22 2015-02-12 コバレントマテリアル株式会社 Cell culture module
US8640560B2 (en) * 2008-03-26 2014-02-04 Emd Millipore Corporation System and method for interfacing sensors to a sterile flow stream
ITTO20080426A1 (en) * 2008-06-05 2009-12-06 Centro Biotecnologie Avanzate BIOREACTOR, IN PARTICULAR FOR THE GENERATION OF ENGINEERED FABRICS
EP2299934A1 (en) * 2008-06-16 2011-03-30 Cytograft Tissue Engineering, Inc. Arterial implants
WO2010022083A2 (en) * 2008-08-18 2010-02-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
US20100168856A1 (en) * 2008-12-31 2010-07-01 Howmedica Osteonics Corp. Multiple piece tissue void filler
US20100168869A1 (en) * 2008-12-31 2010-07-01 Howmedica Osteonics Corp. Tissue integration implant
US8173420B2 (en) * 2009-03-11 2012-05-08 Tissue Growth Technologies Corporation Cell seeding module
US8492135B2 (en) * 2009-04-03 2013-07-23 Tissue Growth Technologies Corporation Deformable transportable bioreactor chamber
US20110213336A1 (en) 2009-08-05 2011-09-01 Cucin Robert L Method of and apparatus for sampling, processing and collecting tissue and reinjecting the same into human patients
US8465471B2 (en) 2009-08-05 2013-06-18 Rocin Laboratories, Inc. Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient
US8348929B2 (en) 2009-08-05 2013-01-08 Rocin Laboratories, Inc. Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient
EP2926821B1 (en) 2010-03-05 2019-12-25 Tissue Genesis, LLC Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells
US9090863B2 (en) 2010-05-17 2015-07-28 Pall Corporation System for seeding cells onto three dimensional scaffolds
AU2010353739B2 (en) * 2010-05-17 2014-03-27 Pall Corporation System for seeding cells onto three dimensional scaffolds
CA2741283A1 (en) * 2010-05-28 2011-11-28 University Health Network Dynamic flow imaging phantom and model therefor
SG178637A1 (en) * 2010-08-24 2012-03-29 Agency Science Tech & Res A mechanical stretching device
WO2012118304A2 (en) * 2011-02-28 2012-09-07 주식회사 코리아본뱅크 Device for incubating allogeneic soft tissue implant
KR101313769B1 (en) 2011-02-28 2013-10-01 주식회사 셀루메드 Device for culturing soft tissue homograft
EP2697622A4 (en) * 2011-04-15 2014-10-08 Univ Aalto Foundation In vitro test method for implant materials
US9606035B2 (en) 2011-12-21 2017-03-28 Ta Instruments-Waters Llc System for mechanical stimulation and characterization of biologic samples
US10449026B2 (en) 2012-06-26 2019-10-22 Biostage, Inc. Methods and compositions for promoting the structural integrity of scaffolds for tissue engineering
US10711238B2 (en) 2012-10-02 2020-07-14 Repligen Corporation Method for proliferation of cells within a bioreactor using a disposable pumphead and filter assembly
US20140093952A1 (en) * 2012-10-02 2014-04-03 David Serway Bioreactor Tangential Flow Perfusion Filter System
US11034928B2 (en) 2014-07-23 2021-06-15 Clemson University Research Foundation Modular bioreactor, compliance chamber for a bioreactor, and cell seeding apparatus
US10022225B2 (en) 2014-07-23 2018-07-17 Clemson University Research Foundation Self-adjusting tissue holder
US10293082B2 (en) 2014-07-23 2019-05-21 Clemson University Research Foundation Decellularization method and system and decellularized tissue formed thereby
US10443028B2 (en) * 2015-03-20 2019-10-15 Chung-Ang University Industry-Academic Cooperation Foundation Cell culture apparatus
US10624992B2 (en) * 2016-05-16 2020-04-21 The General Hospital Corporation Human airway stem cells in lung epithelial engineering
US20190264158A1 (en) * 2016-07-22 2019-08-29 Nissan Chemical Corporation Method for producing liquid medium composition and production device used therefor
CN109689853B (en) 2016-08-27 2022-08-23 三维生物科技有限公司 Bioreactor
US11292999B2 (en) * 2016-08-30 2022-04-05 Finesse Solutions, Inc. Bioreactor with multiple coupled vessels
JP6848273B2 (en) * 2016-09-02 2021-03-24 東洋紡株式会社 Cell culture device
CN114958772A (en) 2017-09-01 2022-08-30 隆萨沃克斯维尔股份有限公司 End-to-end cell therapy automation
CN108371570B (en) * 2017-10-24 2023-10-31 杭州启明医疗器械股份有限公司 Interventional heart valve recyclable conveying system with stable operation
EP3505613A1 (en) * 2017-12-27 2019-07-03 Industrial Technology Research Institute Cell culture module, cell culture system and cell culture method
KR20210107749A (en) 2018-12-21 2021-09-01 옥테인 바이오테크 인코포레이티드 Carousel for modular biological production units
US11718833B2 (en) 2018-12-21 2023-08-08 Lonza Walkersville, Inc. Automated production of viral vectors
WO2020132743A1 (en) 2018-12-28 2020-07-02 Octane Biotech Inc. Cell culture and tissue engineering systems with controlled environmental zones
US11484410B2 (en) * 2019-02-07 2022-11-01 Medical Implant Testing Lab, Inc. Modular and multifunctional apparatus for accelerated durability assessment of medical devices under cyclic pressure loading
KR20210125510A (en) 2019-02-08 2021-10-18 론자 워커스빌 아이엔씨. Cell Concentration Methods and Apparatus for Use in Automated Bioreactors
TW202039818A (en) * 2019-04-25 2020-11-01 中國醫藥大學 Cell sample stimulation device including a base seat unit, at least one movable member, and at least one magnetic attraction member
JP6881798B1 (en) * 2020-08-08 2021-06-02 ティシューバイネット株式会社 A three-dimensional cell structure having a valve function, a method for producing the same, and a support

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734851A (en) * 1969-12-29 1973-05-22 K Matsumura Method and device for purifying blood
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
US4050893A (en) * 1974-07-22 1977-09-27 Hancock Laboratories, Inc. Arrangement for preparing natural tissue for implantation
US4015590A (en) * 1976-04-12 1977-04-05 Baylor College Of Medicine Balloon activated blood pump
US4372743A (en) * 1981-06-22 1983-02-08 American Hospital Supply Corp. Low-pressure fixation of valvular tissue intended for implantation
US4417861A (en) * 1981-08-10 1983-11-29 Monsanto Company Cell culture pumping system
US4546642A (en) * 1984-08-17 1985-10-15 Dynatek, Inc. Accelerated heart valve testing apparatus and methods
US4804628A (en) * 1984-10-09 1989-02-14 Endotronics, Inc. Hollow fiber cell culture device and method of operation
US5035708A (en) * 1985-06-06 1991-07-30 Thomas Jefferson University Endothelial cell procurement and deposition kit
US5230693A (en) * 1985-06-06 1993-07-27 Thomas Jefferson University Implantable prosthetic device for implantation into a human patient having a surface treated with microvascular endothelial cells
US4639422A (en) * 1986-02-03 1987-01-27 Monsanto Company Cell culture filter apparatus and method
US4911713A (en) * 1986-03-26 1990-03-27 Sauvage Lester R Method of making vascular prosthesis by perfusion
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
CH671683A5 (en) * 1987-03-05 1989-09-29 Sulzer Ag
US4835102A (en) * 1987-03-31 1989-05-30 Eugene Bell Tissue equivalent test systems
US4839280A (en) * 1987-05-04 1989-06-13 Banes Albert J Apparatus for applying stress to cell cultures
US5043260A (en) * 1987-11-02 1991-08-27 Rhode Island Hospital Perfusion device with hepatocytes
US5081035A (en) * 1988-04-18 1992-01-14 The University Of Michigan Bioreactor system
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
US5153131A (en) * 1990-12-11 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration High aspect reactor vessel and method of use
US5308764A (en) * 1988-06-30 1994-05-03 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Multi-cellular, three-dimensional living mammalian tissue
US5155034A (en) * 1988-06-30 1992-10-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional cell to tissue assembly process
US4988623A (en) * 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US5153136A (en) * 1988-07-22 1992-10-06 Vandenburgh Herman H Apparatus for growing tissue specimens in vitro
EP0471747A4 (en) * 1989-05-05 1992-06-03 Invitron Corporation Cell culture system
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
AU626686B2 (en) * 1989-06-09 1992-08-06 Medtronic, Inc. Dynamic fixation of porcine aortic valves
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
CA2035907A1 (en) * 1990-02-08 1991-08-09 Phillip M. Lintilhac Instrument for the application of controlled mechanical loads to tissues in sterile cultures
US5217899A (en) * 1990-08-24 1993-06-08 The General Hospital Corporation Cell stretching apparatus
US5176153A (en) * 1990-11-02 1993-01-05 Eberhardt Allen C Heart chamber simulator with electronic accelerated heart valve wear and fatigue test apparatus and method
US5163955A (en) * 1991-01-24 1992-11-17 Autogenics Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment
JPH06505187A (en) * 1991-02-14 1994-06-16 バクスター インターナショナル インコーポレーテッド Flexible biograft material and method for manufacturing the same
US5272909A (en) * 1991-04-25 1993-12-28 Baxter International Inc. Method and device for testing venous valves
GB9116036D0 (en) * 1991-07-25 1991-09-11 Univ Leicester Preparing grafts for implantation
WO1993012805A1 (en) * 1992-01-02 1993-07-08 Regents Of The University Of Michigan Methods for regulatory lineages of human hematopoietic cells
EP0629236B1 (en) * 1992-03-04 2002-10-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietic cells
WO1994025584A1 (en) * 1993-04-28 1994-11-10 Johns Hopkins University School Of Medicine Chronic endothelial cell culture under flow
US5686303A (en) * 1994-12-30 1997-11-11 Korman; Joshua Method of growing vertebrate skin in vitro
US5846828A (en) * 1995-06-07 1998-12-08 Advanced Tissue Sciences Apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing tissue, synthetic, or mechanical heart valves orvalve segments
WO1996034090A1 (en) * 1995-04-27 1996-10-31 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native vascular grafts
US5792603A (en) * 1995-04-27 1998-08-11 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts
US5763267A (en) * 1996-04-16 1998-06-09 Advanced Tissue Sciences Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures

Also Published As

Publication number Publication date
EP1042448A1 (en) 2000-10-11
AU2022899A (en) 1999-07-19
WO1999033951A1 (en) 1999-07-08
AU772414B2 (en) 2004-04-29
JP4104822B2 (en) 2008-06-18
JP2002500004A (en) 2002-01-08
KR20010024824A (en) 2001-03-26
US6121042A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
AU772414B2 (en) Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
AU723286B2 (en) Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts
AU703117B2 (en) Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native vascular grafts
US6060306A (en) Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs
US5846828A (en) Apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing tissue, synthetic, or mechanical heart valves orvalve segments
Hoerstrup et al. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves
US6174719B1 (en) Cardiovascular bioreactor apparatus and method
US7326564B2 (en) Flow system for medical device evaluation and production
AU3209400A (en) Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic, or native vascular grafts

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20031230